Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib
Clinical trial NCT03235245 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03235245
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-30
- Primary completion
- 2023-10-24
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.